Nuvation Bio Inc Class A (NUVB)
R&D Expense Growth
-12.51%
Quarterly · Period ending:
NUVB R&D Expense Growth
Latest reported-12.51%period ending
Latest reported-12.51%period ending
NUVB Quarterly R&D Growth (QoQ) (0.00% → -12.51%)
Latest values, visible window
High-resolution chart · PNG
NUVB r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -12.5146% | |
| 2.1868% | |
| 18.8969% | |
| 5.4236% | |
| 11.2231% | |
| -16.0347% | |
| 5.6543% | |
| -93.8961% | |
| 3,437.7433% | |
| -16.3442% | |
| -17.2943% | |
| -0.156% | |
| -1.0486% | |
| 11.3568% | |
| -20.7711% | |
| -26.3744% | |
| 39.5243% | |
| -5.7858% | |
| 28.5013% | |
| 22.0037% | |
| -11.6191% | |
| 70.0835% | |
| 8.2184% | |
| 17.4541% | |
| 0.6854% | |
| -17.1023% | |
| 118.0377% | |
| -34.2135% | |
| 0% | |
| 0% |